scorecard

You Searched For "Oxford coronavirus" and got 20 results


Sort By:


Business Insider Latest Story Image
2 mins read

Oxford researchers are seeking volunteers willing to get COVID-19 deliberately for a human challenge trial

Britain is the first country to conduct a human challenge trial, exposing people to a low dose of t…

Andrea Michelson   


Business Insider Latest Story Image
2 mins read

Coronavirus epidemic first hit over 21,000 years ago, says a study

The most recent common ancestor of sarbecoviruses — the family of coronaviruses to which SARS-CoV b…

Business Insider Latest Story Image
3 mins read

UK study states that Oxford/AstraZeneca vaccine is 80% effective against B1.617.2 variant of the Coronavirus

According to The Telegraph' newspaper, the latest study's findings were presented to a meeting…

PTI   


Business Insider Latest Story Image
3 mins read

Scientists uncover more data on blood clotting side effect of Covid jab

Scientists have uncovered more knowledge about the risk of developing a very rare blood clotting co…

PTI   


Business Insider Latest Story Image
2 mins read

How AstraZeneca and Oxford blew their vaccine moment

These are Business Insider's biggest healthcare stories for November 30.

Lydia Ramsey Pflanzer   


Business Insider Latest Story Image
2 mins read

The Oxford COVID-19 vaccine will only cost the Indian government $3 per dose, reveals Adar Poonawalla

The CEO of Serum Institute of India (SII), the company conducting the clinical trials of the vac…

Business Insider Latest Story Image
2 mins read

Oxford's COVID-19 vaccine is safe and produces an immune response in older adults, encouraging early trial results suggest

Results of phase 3 trials — which will show whether the Oxford University vaccine can prevent COVID…

Grace Dean   


Business Insider Latest Story Image
2 mins read

Oxford’s COVID-19 vaccine: Phase III human trials begin in India

Serum Institute is likely to conduct the Phase III trials on 1,500 volunteers across 14 locati…

Business Insider Latest Story Image
3 mins read

Serum Institute of India can resume clinical trial of Oxford COVID-19 vaccine, says DCGI

SII has also been asked to submit to the DCGI's office details of medication used in accordance wit…

PTI   


Business Insider Latest Story Image
1 min read

Australia begins production of Oxford-developed Covid-19 vaccine

Despite still undergoing clinical trials, the vaccine, which was co-developed by pharmaceutical …

Business Insider Latest Story Image
3 mins read

Oxford-Astrazeneca COVID-19 Vaccine: Phase II trials will begin in India today

"To start with we have identified five volunteers who will undergo COVID-19 and antibodies tests…

Business Insider Latest Story Image
2 mins read

Serum Institute may begin human trials of Oxford-AstraZeneca’s COVID-19 vaccine candidate from August 25

The trials will be held at PGIMER Chandigarh, AIIMS in Delhi, ABJ Medical College in Pune, Rajen…

Business Insider Latest Story Image
2 mins read

One dose of Pfizer or AstraZeneca vaccine was highly effective at preventing coronavirus in older people, real-world data from South Korea suggests

It is not clear from South Korea's data how long protection against COVID-19 from a single shot las…

Dr. Catherine Schuster-Bruce   


Business Insider Latest Story Image
6 mins read

AstraZeneca's missteps and murky data sewed worldwide confusion that undermined trust - but don't rule the shot out yet

How effective is AstraZeneca's vaccine? That's not fully clear yet. It depends on the dosing and th…

Aria Bendix   


Business Insider Latest Story Image
1 min read

Oxford and Serum Institute of India begin human trials of a new COVID-19 vaccine in Australia

According to Sumi Biswas, CEO SpyBiotech, the Serum Institute of India — which is running the ph…

PTI   


Business Insider Latest Story Image
3 mins read

One dose of the AstraZeneca or Pfizer vaccine provides protection against COVID-19 that lasts at least 10 weeks, study finds

One dose of a Pfizer-BioNTech or AstraZeneca-Oxford vaccine reduced COVID-19 infections by 65% in a…

Dr. Catherine Schuster-Bruce   


Business Insider Latest Story Image
1 min read

Watch: Insider answers your questions about the risk of rare but serious blood clots following some COVID-19 vaccines

Insider discussed the risks and benefits of COVID-19 vaccines from AstraZeneca and Johnson & Johnso…

Dr. Catherine Schuster-Bruce,…   


Business Insider Latest Story Image
2 mins read

AstraZeneca's COVID-19 vaccine enters Phase-III trial in the US

The Covid-19 vaccine candidate developed by Oxford University in partnership with the UK-based g…

Business Insider Latest Story Image
2 mins read

The Oxford COVID-19 vaccine will soon be tested on children as young as 6

It's the first vaccine research to be carried out in children so young, following Pfizer and Modern…

Rachel Hosie